Skip to main content
Clinical Trials/CTRI/2023/07/055692
CTRI/2023/07/055692
Not yet recruiting
Phase 2

Effectiveness of Homoeopathic Remedies selected based on Boger Boenninghausen Characteristics and Repertory (BBCR) in the treatment of Rheumatoid Arthritis - NI

ational Institute of Homoeopathy0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified
Sponsor
ational Institute of Homoeopathy
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
ational Institute of Homoeopathy

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients diagnosed with RA according to the ACR\-EULAR classification criteria.
  • 2\.Cases with characteristic particular symptoms suitable for Repertorisation in Boger Boenninghausenâ??s Characteristics and Repertory (BBCR).
  • 3\.Age between 25\-55 years
  • 4\.Patients of all gender
  • 5\.patients belonging to all religion and socioeconomic group
  • 6\.Both male and female patients.
  • 7\.Patient willing to take part in the study and giving informed consent.

Exclusion Criteria

  • 1\.Currently receiving homoeopathic treatment for any chronic condition(s).
  • 2\.Patients with known comorbidities viz. diabetes mellitus, hypertension serious systemic unevaluated or uncontrolled diseases affecting quality of life or on other treatment therapies; psychiatric illness and continuing with medication for this kind will be excluded during screening.
  • 3\.Patients taking Steroid medicines for RA
  • 4\.Substance abuse and/or dependence.
  • 5\.Self\-reported immune\-compromised state.
  • 6\.Pregnant and lactating mothers

Outcomes

Primary Outcomes

Not specified

Similar Trials